Ionis Pharmaceuticals Statistics
Total Valuation
IONS has a market cap or net worth of $13.14 billion. The enterprise value is $13.00 billion.
Important Dates
The last earnings date was Wednesday, February 25, 2026, before market open.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IONS has 165.19 million shares outstanding. The number of shares has increased by 7.02% in one year.
| Current Share Class | 165.19M |
| Shares Outstanding | 165.19M |
| Shares Change (YoY) | +7.02% |
| Shares Change (QoQ) | +1.40% |
| Owned by Insiders (%) | 0.81% |
| Owned by Institutions (%) | 103.83% |
| Float | 163.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.84 |
| Forward PS | 14.66 |
| PB Ratio | 27.37 |
| P/TBV Ratio | 26.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.83, with a Debt / Equity ratio of 5.35.
| Current Ratio | 3.83 |
| Quick Ratio | 3.51 |
| Debt / Equity | 5.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.22 |
Financial Efficiency
Return on equity (ROE) is -70.80% and return on invested capital (ROIC) is -90.05%.
| Return on Equity (ROE) | -70.80% |
| Return on Assets (ROA) | -7.31% |
| Return on Invested Capital (ROIC) | -90.05% |
| Return on Capital Employed (ROCE) | -13.92% |
| Weighted Average Cost of Capital (WACC) | 5.67% |
| Revenue Per Employee | $882,798 |
| Profits Per Employee | -$356,770 |
| Employee Count | 1,402 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 82.58 |
Taxes
In the past 12 months, IONS has paid $1.79 million in taxes.
| Income Tax | 1.79M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +139.98% in the last 52 weeks. The beta is 0.36, so IONS's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +139.98% |
| 50-Day Moving Average | 81.38 |
| 200-Day Moving Average | 62.00 |
| Relative Strength Index (RSI) | 42.86 |
| Average Volume (20 Days) | 2,125,500 |
Short Selling Information
The latest short interest is 15.49 million, so 9.38% of the outstanding shares have been sold short.
| Short Interest | 15.49M |
| Short Previous Month | 15.54M |
| Short % of Shares Out | 9.38% |
| Short % of Float | 9.46% |
| Short Ratio (days to cover) | 6.96 |
Income Statement
In the last 12 months, IONS had revenue of $943.71 million and -$381.39 million in losses. Loss per share was -$2.38.
| Revenue | 943.71M |
| Gross Profit | 12.18M |
| Operating Income | -381.68M |
| Pretax Income | -379.60M |
| Net Income | -381.39M |
| EBITDA | -369.24M |
| EBIT | -381.68M |
| Loss Per Share | -$2.38 |
Full Income StatementBalance Sheet
The company has $2.68 billion in cash and $2.62 billion in debt, with a net cash position of $64.58 million or $0.39 per share.
| Cash & Cash Equivalents | 2.68B |
| Total Debt | 2.62B |
| Net Cash | 64.58M |
| Net Cash Per Share | $0.39 |
| Equity (Book Value) | 489.09M |
| Book Value Per Share | 2.99 |
| Working Capital | 2.21B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$268.58 million and capital expenditures -$51.44 million, giving a free cash flow of -$320.03 million.
| Operating Cash Flow | -268.58M |
| Capital Expenditures | -51.44M |
| Free Cash Flow | -320.03M |
| FCF Per Share | -$1.94 |
Full Cash Flow StatementMargins
Gross margin is 1.29%, with operating and profit margins of -40.45% and -40.41%.
| Gross Margin | 1.29% |
| Operating Margin | -40.45% |
| Pretax Margin | -40.22% |
| Profit Margin | -40.41% |
| EBITDA Margin | -39.13% |
| EBIT Margin | -40.45% |
| FCF Margin | n/a |
Dividends & Yields
IONS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.02% |
| Shareholder Yield | -7.02% |
| Earnings Yield | -2.92% |
| FCF Yield | -2.45% |
Dividend DetailsAnalyst Forecast
The average price target for IONS is $85.91, which is 8.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $85.91 |
| Price Target Difference | 8.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | 30.44% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IONS has an Altman Z-Score of 1.13 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.13 |
| Piotroski F-Score | 3 |
